Co-Chair of the European Cancer Organisation’s Impact of COVID-19 on Cancer Special Network, Prof. Mark Lawler (Queen’s University, Belfast, UK) speaks to touchONCOLOGY about the impact the COVID-19 pandemic has had on cancer care and the newly launched ‘Time to Act’ campaign. Further information about the campaign can be found on the European Cancer Organisation’s website at https://www.europeancancer.org/timetoact.
- How has the COVID-19 pandemic impacted on cancer care across Europe? (0:18)
- Could you tell us a little about the ‘Time to Act’ campaign and its objectives? (1:04)
- What advice has the European Cancer Organisation given to governments? (2:24)
- What are the major obstacles to addressing the current unmet needs in cancer care and how can they be overcome? (3:02)
Disclosures: Unrestricted educational grant from Pfizer for research unrelated to this work. Honoraria from Pfizer, EMD Serono , Roche and Carnall Farrar unrelated to this work.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Helen Fowler.
Share this Video
Related Videos In Supportive Cancer Care
Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!
Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO), shares what we can look forward to at the annual meeting in November!
Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register
touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to. Questions 1. What can we expect from ESSO […]
Professor Domenico D’Ugo: Current Initiatives at ESSO and Looking to the Future
Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our valued media partners at touchONCOLOGY, discusses the latest from the society and his hopes for oncology management post-COVID19 in 2022. Questions 1. Please tell us about any initiatives that ESSO are currently working on? (00:15-02:24) 2. What can we expect in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!